High-throughput kinetic screening of hybridomas to identify high-affinity antibodies using bio-layer interferometry

Journal of Biomolecular Screening

Volumn 20, Issue 4, 2015, Pages 498-507

  Lad, Latesh ^a   Clancy, Sheila ^a   Kovalenko, Maria ^a   Liu, Chian ^a   Hui, Terence ^b   Smith, Victoria ^a   Pagratis, Nikos ^a  

^a GILEAD SCIENCES   (United States)

^b Pall ForteBio Corporation   (United States)

Author keywords

bio layer interferometry; high throughput screening; label free

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BIO LAYER INTERFEROMETRY; BIOSENSOR; CLONE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; HYBRIDOMA; INTERFEROMETRY; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; SUPERNATANT; IMMUNOLOGY;

ANTIBODY AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYBRIDOMAS; KINETICS;

EID: 84925719386     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057114560123     Document Type: Article

References (29)

1. Nelson A. L., Dhimolea E., Reichert J. M.. Development Trends for Human Monoclonal Antibody Therapeutics. Nature Rev. Drug Discov. 2010 ; 9: 767-774
2. Beck A., Wurch T., Bailly C., et al. Strategies and Challenges for the Next Generation of Therapeutic Antibodies. Nature Rev. Immunol. 2010 ; 10: 345-352
3. Reichert J. M.. Antibodies to Watch in 2014. mAbs. 2014 ; 6: 5-14
4. Carter P. J.. Potent Antibody Therapeutics by Design. Nature Rev. Immunol. 2006 ; 6: 343-357
5. Köhler G., Milstein C.. Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity. Nature. 1975 ; 256: 495-497
6. Marks J. D., Hoogenboom H. R., Bonnert T. P., et al. By-Passing Immunization. Human Antibodies from V-Gene Libraries Displayed on Phage. J. Mol. Biol. 1991 ; 222: 581-597
7. Concepcion J., Witte K., Wartchow C., et al. Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization. Comb. Chem. High-Throughput Screen. 2009 ; 12: 791-800
8. Rich R. L., Papalia G. A., Flynn P. J., et al. A Global Benchmark Study Using Affinity-Based Biosensors. Anal. Biochem. 2009 ; 386: 194-216
9. Canziani G. A., Klakamp S., Myszka D. G.. Kinetic Screening of Antibodies from Crude Hybridoma Samples Using Biacore. Anal. Biochem. 2004 ; 325: 301-307
10. Säfsten P., Klakamp S. L., Drake A. W., et al. Screening Antibody-Antigen Interactions in Parallel Using Biacore A100. Anal. Biochem. 2006 ; 353: 181-190
11. Hoogenboom H. R.. Selecting and Screening Recombinant Antibody Libraries. Nature Biotech. 2005 ; 23: 1105-1116
12. Hoogenboom H. R.. Overview of Antibody Phage-Display Technology and Its Applications. Meth. Mol. Biol. 2002 ; 178: 1-37
13. Liang M., Klakamp S. L., Funelas C., et al. Detection of High- and Low-Affinity Antibodies against a Human Monoclonal Antibody Using Various Technology Platforms. Assay Drug Devel. Tech. 2007 ; 5: 655-662
14. McHugh T. M., Miner R. C., Logan L. H., et al. Simultaneous Detection of Antibodies to Cytomegalovirus and Herpes Simplex Virus by Using Flow Cytometry and a Microsphere-Based Fluorescence Immunoassay. J. Clin. Microbiol. 1998 ; 26: 1957-1961
15. Fulton R. J., McDade R. L., Smith P. L., et al. Advanced Multiplexed Analysis with the FlowMetrix System. Clin. Chem. 1997 ; 43: 1749-1756
16. Kettman J. R., Davies T., Chandler D., et al. Classification and Properties of 64 Multiplexed Microsphere Sets. Cytometry. 1998 ; 33: 234-243
17. Cervino C., Weber E., Knopp D., et al. Comparison of Hybridoma Screening Methods for the Efficient Detection of High-Affinity Hapten-Specific Monoclonal Antibodies. J. Immunol. Meth. 2008 ; 329: 184-193
18. Moxness M., Tatarewicz S., Weeraratne D., et al. Immunogenicity Testing by Electrochemiluminescent Detection for Antibodies Directed against Therapeutic Human Monoclonal Antibodies. Clin. Chem. 2005 ; 51: 1983-1985
19. Lu Y., Wong W. L., Meng Y. G.. A High Throughput Electrochemiluminescent Cell-Binding Assay for Therapeutic Anti-CD20 Antibody Selection. J. Immunol. Meth. 2006 ; 314: 74-79
20. Rieger M., Cervino C., Sauceda J. C., et al. Efficient Hybridoma Screening Technique Using Capture Antibody Based Microarrays. Anal. Chem. 2009 ; 81: 2373-2377
21. Daigo K., Sugita S., Mochizuki Y., et al. A Simple Hybridoma Screening Method for High-Affinity Monoclonal Antibodies Using the Signal Ratio Obtained from Time-Resolved Fluorescence Assay. Anal. Biochem. 2006 ; 351: 219-228
22. Degorce F., Card A., Soh S., et al. HTRF: A Technology Tailored for Drug Discovery: A Review of Theoretical Aspects and Recent Applications. Curr. Chem. Genom. 2009 ; 28: 22-32
23. Sasaki K., Glass T. R., Ohmura N.. Validation of Accuracy of Enzyme-Linked Immunosorbent Assay in Hybridoma Screening and Proposal of an Improved Screening Method. Anal. Chem. 2005 ; 77: 1933-1999
24. Ohmura N., Lackie S. J., Saiki H.. An Immunoassay for Small Analytes with Theoretical Detection Limits. Anal. Chem. 2001 ; 73: 3392-3399
25. Blake D. A., Jones R. M., Blake R. C., et al. Antibody-Based Sensors for Heavy Metal Ions. Biosens. Bioelect. 2001 ; 16: 799-809
26. Rich R. L., Myszka D. G.. Why You Should Be Using More SPR Biosensor Technology. Drug Disc. Today Tech. 2004 ; 1: 301-308
27. Usui-Aoki K., Shimada K., Nagano M., et al. A Novel Approach to Protein Expression Profiling Using Antibody Microarrays Combined with Surface Plasmon Resonance Technology. Proteomics. 2005 ; 5: 2396-2401
28. Wassaf D., Kuang G., Kopacz K., et al. High-Throughput Affinity Ranking of Antibodies Using Surface Plasmon Resonance Microarrays. Anal. Biochem. 2006 ; 35: 241-253
29. Ylera F., Harth S., Waldherr D., et al. Off-Rate Screening for Selection of High-Affinity Anti-Drug Antibodies. Anal. Biochem. 2013 ; 441: 208-313